Application

16128831 · ANTI-ACTIVIN A ANTIBODIES AND USES THEREOF

Filed 2018-09-12 · Granted · Patent 11542325 (2023-01-03) The official file ↗The patent and its PDF ↗ · Art unit 1644 · Examiner Maher M Haddad Typical · CPC A61P 1/00 · Amgen Inc. · AMGEN INC.

Office actions

first was Restriction requirement

RCEs

no appeal

To first action

13.7 mo

to disposition 51.7 mo

Statutes raised

101 DP

3 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.